Sector Snap: Inhaled Insulin NEW YORK—An already faltering pharmaceutical industry effort to develop inhaled insulin suffered another severe blow Wednesday after Pfizer Inc. said its now-discontinued Exubera could cause lung cancer.
Date: April 9, 2008